Valosin containing protein (VCP) has emerged as a central protein in the regulation of the protein quality control (PQC) system. VCP mutations are causative of multisystem proteinopathies, which include neurodegenerative diseases (NDs), and share various signs of altered proteostasis, mainly associated with autophagy malfunctioning. Autophagy is a complex multistep degradative system essential for the maintenance of cell viability, especially in post-mitotic cells as neurons and differentiated skeletal muscle cells. Interestingly, many studies concerning NDs have focused on autophagy impairment as a pathological mechanism or autophagy activity boosting to rescue the pathological phenotype. The role of VCP in autophagy has been widely debated, but recent findings have defined new mechanisms associated with VCP activity in the regulation of autophagy, showing that VCP is involved in different steps of this pathway. Here we will discuss the multiple activity of VCP in the autophagic pathway underlying its leading role either in physiological or pathological conditions. A better understanding of VCP complexes and mechanisms in regulating autophagy could define the altered mechanisms by which VCP directly or indirectly causes or modulates different human diseases and revealing possible new therapeutic approaches for NDs.

Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy / V. Ferrari, R. Cristofani, B. Tedesco, V. Crippa, M. Chierichetti, E. Casarotto, M. Cozzi, F. Mina, M. Piccolella, M. Galbiati, P. Rusmini, A. Poletti. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1422-0067. - 23:4(2022 Feb 09), pp. 1939.1-1939.19. [10.3390/ijms23041939]

Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy

V. Ferrari
Primo
;
R. Cristofani
Secondo
;
B. Tedesco;V. Crippa;M. Chierichetti;E. Casarotto;M. Cozzi;F. Mina;M. Piccolella;M. Galbiati;P. Rusmini
Penultimo
;
A. Poletti
Ultimo
2022

Abstract

Valosin containing protein (VCP) has emerged as a central protein in the regulation of the protein quality control (PQC) system. VCP mutations are causative of multisystem proteinopathies, which include neurodegenerative diseases (NDs), and share various signs of altered proteostasis, mainly associated with autophagy malfunctioning. Autophagy is a complex multistep degradative system essential for the maintenance of cell viability, especially in post-mitotic cells as neurons and differentiated skeletal muscle cells. Interestingly, many studies concerning NDs have focused on autophagy impairment as a pathological mechanism or autophagy activity boosting to rescue the pathological phenotype. The role of VCP in autophagy has been widely debated, but recent findings have defined new mechanisms associated with VCP activity in the regulation of autophagy, showing that VCP is involved in different steps of this pathway. Here we will discuss the multiple activity of VCP in the autophagic pathway underlying its leading role either in physiological or pathological conditions. A better understanding of VCP complexes and mechanisms in regulating autophagy could define the altered mechanisms by which VCP directly or indirectly causes or modulates different human diseases and revealing possible new therapeutic approaches for NDs.
VCP; autophagy; lysophagy; TFEB; TFE3; NF-κB; neurodegenerative disease
Settore BIO/13 - Biologia Applicata
Settore BIO/09 - Fisiologia
   Alternative translation initiation as a novel strategy to block toxicity of the mutant Androgen Receptor in SBMA
   TRANS-ALS
   FONDAZIONE TELETHON ETS
   GGP19128

   Unveiling regenerative and metabolic features of SBMA muscle cells to identify new therapeutic targets
   No RAn for old man
   KENNEDY'S DISEASE ASSOCIATION

   Selective translation of androgen receptor isoform A to prevent polyQ mediated toxicity in Kennedy’s disease
   Target-RAN
   KENNEDY'S DISEASE ASSOCIATION

   Motor neuron degeneration in Spinal and Bulbar Muscular Atrophy: molecular approaches to counteract mutant androgen receptor neurotoxicity
   ALS_HSPB8
   FONDAZIONE TELETHON ETS
   GGP14039

   Translating molecular mechanisms into ALS risk and patient's well-being
   CureALS
   FONDAZIONE REGIONALE PER LA RICERCA BIOMEDICA
   2015-0023

   Extracellular vescicles in the pathogenesis of frontotemporal dementia
   Co-ALS
   FONDAZIONE CARIPLO
   2017-0747

   RAN translation of normal and expanded nucleotide repeat containing transcripts to neurotoxic polypetides in neurodegenerative diseases
   MLOMALS
   FONDAZIONE CARIPLO
   2014-0686

   Targeting RAN translation in ALS (Target-RAN)
   EX_ALS
   FONDAZIONE ITALIANA DI RICERCA PER LA SLA - SCLEROSI LATERALE AMIOTROFICA - ARISLA

   The involvement of the small heat shock protein HSPB8 in amyotrophic lateral sclerosis
   AFM-TELETHON - ASS. FRANCAISE CONTRE LES MYOPATHIES

   Upregulation of HSPB8 as potential therapeutic approach in familial and sporadic ALS
   ALS_HSPB8
   FONDAZIONE ITALIANA DI RICERCA PER LA SLA - SCLEROSI LATERALE AMIOTROFICA - ARISLA
   ALS_HSPB8

   Stress granules and proteostasis in motor neurons: towards a mechanistic understanding of ALS (CureALS)
   CureALS
   MINISTERO DELL'ISTRUZIONE E DEL MERITO

   Colchicine for Amyotrophic Lateral Sclerosis: a phase II, randomized, double blind, placebo controlled, multicenter clinical trial (Co-ALS)
   Co-ALS
   AGENZIA ITALIANA DEL FARMACO - AIFA
   AIFA-2016-02364678

   Membrane-less organelle pathology in ALS: identification of causes and rescuing factors (MLOMALS)
   MLOMALS
   FONDAZIONE ITALIANA DI RICERCA PER LA SLA - SCLEROSI LATERALE AMIOTROFICA - ARISLA

   The interplay between the “rna/protein quality control system” and “exosomes” as a spreading mechanism in amyotrophic lateral sclerosis (EX_ALS)
   EX_ALS
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   2017F2A2C5_001

   From RNA to Protein toxicity in motorneuron diseases
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   2015LFPNMN_001
9-feb-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
ijms-23-01939.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 920.79 kB
Formato Adobe PDF
920.79 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/905829
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 17
social impact